Evommune Inc.
EVMN | NYSE
$6.22
-$0.51 (-7.58%)
Nov 2, 2026, 11:42 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 |
|---|---|---|---|
Net Income | -68.87M | -66.81M | -34.05M |
Depreciation & Amortization | 1.39M | 1.29M | 1M |
Stock-Based Compensation | n/a | n/a | n/a |
Other Working Capital | -3.28M | 918K | 3.22M |
Other Non-Cash Items | -4.84M | -98K | -261K |
Deferred Income Tax | n/a | n/a | n/a |
Change in Working Capital | -4.12M | 7.42M | 3.34M |
Operating Cash Flow | -76.44M | -58.2M | -29.97M |
Capital Expenditures | -235K | -88K | -118K |
Cash Acquisitions | n/a | n/a | n/a |
Purchase of Investments | -199.17M | -90.26M | -91.31M |
Sales Maturities Of Investments | 84.1M | 86.35M | 43M |
Other Investing Acitivies | n/a | n/a | n/a |
Investing Cash Flow | -115.31M | -3.99M | -48.43M |
Debt Repayment | -373K | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a |
Other Financial Acitivies | -1.22M | -423K | -230K |
Financial Cash Flow | 220.76M | 49.42M | 63.75M |
Net Cash Flow | 27.81M | -12.77M | 29.02M |
Free Cash Flow | -76.68M | -58.28M | -30.09M |
Adj. Free Cash Flow | -76.68M | -58.28M | -30.09M |
Maintenance CapEx | n/a | n/a | -118K |
Growth CapEx | -235K | -88K | n/a |
Owner Earnings | -76.44M | -58.2M | -30.09M |
Add to Watchlist
Select watchlists to add or remove EVMN